{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:59:08Z","timestamp":1787828348455,"version":"build-2784847793"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Leslie Dan Faculty of Pharmacy Internal Fund","award":["923465"],"award-info":[{"award-number":["923465"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12974-017-0957-8","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T10:58:46Z","timestamp":1505127526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation"],"prefix":"10.1186","volume":"14","author":[{"given":"Amila","family":"Omeragic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Tozammel","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U-yeong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"key":"957_CR1","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.76.13.6689-6700.2002","volume":"76","author":"NQ Liu","year":"2002","unstructured":"Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, et al. Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol. 2002;76:6689\u2013700.","journal-title":"J Virol"},{"key":"957_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0039565","volume":"7","author":"S Dohgu","year":"2012","unstructured":"Dohgu S, Ryerse JS, Robinson SM, Banks WA. Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrier. PLoS One. 2012;7:1\u201312.","journal-title":"PLoS One"},{"key":"957_CR3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11481-010-9205-z","volume":"5","author":"KA Lindl","year":"2010","unstructured":"Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J NeuroImmune Pharmacol. 2010;5:294\u2013309.","journal-title":"J NeuroImmune Pharmacol"},{"key":"957_CR4","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001;410:988\u201394.","journal-title":"Nature"},{"key":"957_CR5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/jcbfm.2013.240","volume":"34","author":"W Huang","year":"2014","unstructured":"Huang W, Chen L, Zhang B, Park M, Toborek M. PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice. J Cereb Blood Flow Metab. 2014;34:646\u201353.","journal-title":"J Cereb Blood Flow Metab"},{"key":"957_CR6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/mol.106.025973","volume":"70","author":"PT Ronaldson","year":"2006","unstructured":"Ronaldson PT, Bendayan R. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharmacol. 2006;70:1087\u201398.","journal-title":"Mol Pharmacol"},{"key":"957_CR7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1471-4159.2008.05479.x","volume":"106","author":"PT Ronaldson","year":"2008","unstructured":"Ronaldson PT, Bendayan R. HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. J Neurochem. 2008;106:1298\u2013313.","journal-title":"J Neurochem"},{"key":"957_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-11-91","volume":"11","author":"T Ashraf","year":"2014","unstructured":"Ashraf T, Jiang W, Hoque MT, Henderson J, Wu C, Bendayan R. Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation. J Neuroinflammation. 2014;11:91.","journal-title":"J Neuroinflammation"},{"key":"957_CR9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, et al. HIV-associated neurocognitive disorder\u2014pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12:234\u201348.","journal-title":"Nat Rev Neurol"},{"key":"957_CR10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e3181f4d5bb","volume":"75","author":"P Vivithanaporn","year":"2010","unstructured":"Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, et al. Neurologic disease burden in treated HIV\/AIDS predicts survival: a population-based study. Neurology. 2010;75:1150\u20138.","journal-title":"Neurology"},{"key":"957_CR11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/00207454.2010.520541","volume":"120","author":"GIT Cavalcante","year":"2010","unstructured":"Cavalcante GIT, Capistrano VLM, Cavalcante FSD, Vasconcelos SMM, Mac\u00eado DS, Sousa FCF, et al. Implications of efavirenz for neuropsychiatry: a review. Int J Neurosci. 2010;120:739\u201345.","journal-title":"Int J Neurosci"},{"key":"957_CR12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAD.0b013e328317a702","volume":"23","author":"BM Best","year":"2010","unstructured":"Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, et al. Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2010;23:83\u20137.","journal-title":"AIDS"},{"key":"957_CR13","first-page":"376","volume":"59","author":"BM Best","year":"2013","unstructured":"Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, et al. Low CSF concentrations of the nucleotide reverse transcriptase inhibitor, tenofovir. AIDS. 2013;59:376\u201381.","journal-title":"AIDS"},{"key":"957_CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1592\/phco.26.8.1111","volume":"26","author":"FJ Piacenti","year":"2006","unstructured":"Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy. 2006;26:1111\u201333.","journal-title":"Pharmacotherapy"},{"key":"957_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/QAI.0b013e318256f3bc","volume":"60","author":"A Kamat","year":"2012","unstructured":"Kamat A, Lyons J, Misra V. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr. 2012;60:234\u201343.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"957_CR16","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0000000000000303","volume":"28","author":"E Cassol","year":"2014","unstructured":"Cassol E, Misra V, Dutta A, Morgello S, Gabuzda D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS. 2014;28:1579\u201391.","journal-title":"AIDS"},{"key":"957_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0042-6822(03)00181-8","volume":"312","author":"Z Wang","year":"2003","unstructured":"Wang Z, Pekarskaya O, Bencheikh M, Chao W, Gelbard HA, Ghorpade A, et al. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. J Virol. 2003;312:60\u201373.","journal-title":"J Virol"},{"key":"957_CR18","first-page":"358","volume":"22","author":"RI Melendez","year":"2015","unstructured":"Melendez RI, Roman C, Capo-Velez CM, Lasalde-Dominicci JA. Decreased glial and synaptic glutamate uptake in the striatum of HIV-1 gp120 transgenic mice. J Neuro-Oncol. 2015;22:358\u201365.","journal-title":"J Neuro-Oncol"},{"key":"957_CR19","doi-asserted-by":"crossref","unstructured":"Vesce S, Bezzi P, Rossi D, Meldolesi J, Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 1997;411:107\u20139.","DOI":"10.1016\/S0014-5793(97)00674-1"},{"key":"957_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"B Grygiel-G\u00f3rniak","year":"2014","unstructured":"Grygiel-G\u00f3rniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2014a review. Nutr J. 2014;13:17.","journal-title":"Nutr J"},{"key":"957_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2005.07.006","volume":"168","author":"PE Polak","year":"2005","unstructured":"Polak PE, Kalinin S, Dello Russo C, Gavrilyuk V, Sharp A, Peters JM, et al. Protective effects of a peroxisome proliferator-activated receptor-beta\/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2005;168:65\u201375.","journal-title":"J Neuroimmunol"},{"key":"957_CR22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pnpbp.2014.02.009","volume":"53","author":"JK Barbiero","year":"2014","unstructured":"Barbiero JK, Santiago R, Tonin FS, Boschen S, da Silva LM, Werner MF, et al. PPAR-\u03b1 agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson\u2019s disease. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;53:35\u201344.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"957_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2014.12.027","volume":"349","author":"Z-Q Shao","year":"2015","unstructured":"Shao Z-Q, Liu Z-J. Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: new evidence on neuroprotection in a rat model of global cerebral ischemia. J Neurol Sci. 2015;349:65\u201371.","journal-title":"J Neurol Sci"},{"key":"957_CR24","doi-asserted-by":"crossref","unstructured":"Bernardo A, Minghetti L. Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists. PPAR Res. 2008;2008.","DOI":"10.1155\/2008\/864140"},{"key":"957_CR25","doi-asserted-by":"crossref","unstructured":"Potula R, Ramirez SH, Knipe B, Leibhart J, Heilman D, Morsey B, et al. Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis. AIDS. 2009;22:1539\u201349.","DOI":"10.1097\/QAD.0b013e3283081e08"},{"key":"957_CR26","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1096\/fj.08-121624","volume":"23","author":"W Huang","year":"2009","unstructured":"Huang W, Eum SY, Andr\u00e1s IE, Hennig B, Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J. 2009;23:1596\u2013606.","journal-title":"FASEB J"},{"key":"957_CR27","doi-asserted-by":"crossref","unstructured":"Bernier A, Cleret-buhot A, Zhang Y, Goulet J, Monteiro P. Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication. Retrovirology. 2013; 10:160.","DOI":"10.1186\/1742-4690-10-160"},{"key":"957_CR28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.tips.2015.06.010","volume":"36","author":"S Sauer","year":"2015","unstructured":"Sauer S. Ligands for the nuclear peroxisome proliferator-activated receptor gamma. Trends Pharmacol Sci. 2015;36:688\u2013704.","journal-title":"Trends Pharmacol Sci"},{"key":"957_CR29","doi-asserted-by":"crossref","unstructured":"Ricote M, Glass CK. PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta - Mol Cell Biol Lipids. 2007, 1771:926\u201335.","DOI":"10.1016\/j.bbalip.2007.02.013"},{"key":"957_CR30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/mol.111.076745","volume":"81","author":"MT Hoque","year":"2012","unstructured":"Hoque MT, Robillard KR, Bendayan R. Regulation of breast cancer resistant protein by peroxisome proliferator-activated receptor \u03b1 in human brain microvessel endothelial cells. Mol Pharmacol. 2012;81:598\u2013609.","journal-title":"Mol Pharmacol"},{"key":"957_CR31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2007-11108","volume":"11","author":"JC Strum","year":"2007","unstructured":"Strum JC, Shehee R, Virley D, Richardson J, Mattie M, Selley P, et al. Rosiglitazone induces mitochondrial biogenesis in mouse brain. J Alzheimers Dis. 2007;11:45\u201351.","journal-title":"J Alzheimers Dis"},{"key":"957_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(99)02445-2","volume":"861","author":"CR Pugh","year":"2000","unstructured":"Pugh CR, Johnson JD, Martin D, Rudy JW, Maier SF, Watkins LR. Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Res. 2000;861:8\u201315.","journal-title":"Brain Res"},{"key":"957_CR33","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/sj.jcbfm.9600438","volume":"27","author":"C Romera","year":"2007","unstructured":"Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, et al. Ischemic preconditioning reveals that GLT1\/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab. 2007;27:1327\u201338.","journal-title":"J Cereb Blood Flow Metab"},{"key":"957_CR34","doi-asserted-by":"crossref","unstructured":"Tanaka T, Itoh H, Doi K, Fukunaga Y, Hosoda K, Shintani M, et al. Down regulation of peroxisome proliferator-activated receptor-gamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia. 1999;42:702\u201310.","DOI":"10.1007\/s001250051218"},{"key":"957_CR35","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1523\/JNEUROSCI.1287-16.2016","volume":"36","author":"MK Mamik","year":"2016","unstructured":"Mamik MK, Asahchop EL, Chan WF, Zhu Y, Branton WG, McKenzie BA, et al. Insulin treatment prevents neuroinflammation and neuronal injury with restored neurobehavioral function in models of HIV\/AIDS neurodegeneration. J Neurosci. 2016;36:10683\u201395.","journal-title":"J Neurosci"},{"key":"957_CR36","first-page":"S24","volume":"6","author":"D Gabuzda","year":"2000","unstructured":"Gabuzda D, Wang J. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis. J Neuro-Oncol. 2000;6:S24\u201332.","journal-title":"J Neuro-Oncol"},{"key":"957_CR37","first-page":"251","volume":"5","author":"SK Oh","year":"1992","unstructured":"Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, et al. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr. 1992;5:251\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"957_CR38","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1097\/00002030-200012010-00010","volume":"14","author":"MV Jones","year":"2000","unstructured":"Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS. 2000;14:2709\u201313.","journal-title":"AIDS"},{"key":"957_CR39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O","volume":"54","author":"WA Banks","year":"1998","unstructured":"Banks WA, Kastin AJ. Characterization of lectin-mediated brain uptake of HIV-1 GP120. J Neurosci Res. 1998;54:522\u20139.","journal-title":"J Neurosci Res"},{"key":"957_CR40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/jnr.22720","volume":"89","author":"T Ashraf","year":"2011","unstructured":"Ashraf T, Ronaldson PT, Persidsky Y, Bendayan R. Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes. J Neurosci Res. 2011;89:1773\u201382.","journal-title":"J Neurosci Res"},{"key":"957_CR41","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","volume":"373","author":"PD Home","year":"2009","unstructured":"Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009;373:2125\u201335.","journal-title":"Lancet"},{"key":"957_CR42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","volume":"366","author":"JA Dormandy","year":"2005","unstructured":"Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitazone clinical trial in macrovascular events): a randomised controlled trial. Lancet. 2005;366:1279\u201389.","journal-title":"Lancet"},{"key":"957_CR43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1471-4159.2008.05626.x","volume":"107","author":"W Huang","year":"2008","unstructured":"Huang W, Rha GB, Han M-J, Eum SY, Andr\u00e1s IE, Zhong Y, et al. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J Neurochem. 2008;107:497\u2013509.","journal-title":"J Neurochem"},{"key":"957_CR44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2004.12.015","volume":"161","author":"PD Storer","year":"2005","unstructured":"Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J Neuroimmunol. 2005;161:113\u201322.","journal-title":"J Neuroimmunol"},{"key":"957_CR45","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.4049\/jimmunol.178.3.1904","volume":"178","author":"J Xu","year":"2007","unstructured":"Xu J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia. J Immunol. 2007;178:1904\u201313.","journal-title":"J Immunol"},{"key":"957_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","volume":"32","author":"CM Anderson","year":"2000","unstructured":"Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32:1\u201314.","journal-title":"Glia"},{"key":"957_CR47","first-page":"315","volume":"20","author":"F Vazquez-Santiago","year":"2014","unstructured":"Vazquez-Santiago F, Noel R Jr, Porter JT, Rivera-Amill V. Glutamate metabolism and HIV-associated neurocognitive disorders. J Neuro-Oncol. 2014;20:315\u201331.","journal-title":"J Neuro-Oncol"},{"key":"957_CR48","first-page":"671","volume":"57","author":"C Ferrarese","year":"2001","unstructured":"Ferrarese C, Aliprandi A, Tremolizzo L, Stanzani L, De Micheli A, Dolara A, Frattola L. Increased glutamate in CSF and plasma of patients with HIV dementia. J Neuro-Oncol. 2001;57:671\u20135.","journal-title":"J Neuro-Oncol"},{"key":"957_CR49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1073\/pnas.91.2.494","volume":"91","author":"DJ Benos","year":"1994","unstructured":"Benos DJ, Hahnt BH, Bubient JK, Ghosht SK, Mashburn NA, Chaikin MA, et al. Envelope glycoprotein gpl20 of human immunodeficiency. Proc Natl Acad Sci. 1994;91:494\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"957_CR50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sj.emboj.7600555","volume":"24","author":"R Sitcheran","year":"2005","unstructured":"Sitcheran R, Gupta P, Fisher PB, Baldwin AS. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. EMBO J. 2005;24:510\u201320.","journal-title":"EMBO J"},{"key":"957_CR51","first-page":"328","volume":"12","author":"G Schifitto","year":"2006","unstructured":"Schifitto G, Yiannoutsos CT, Simpson DM, Marra CM, Singer EJ, Kolson DL, et al. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. J Neuro-Oncol. 2006;12:328\u201331.","journal-title":"J Neuro-Oncol"},{"key":"957_CR52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1471-4159.2007.04594.x","volume":"102","author":"N Erdmann","year":"2007","unstructured":"Erdmann N, Zhao J, Lopez AL, Herek S, Curthoys N, Hexum TD, et al. Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. J Neurochem. 2007;102:539\u201349.","journal-title":"J Neurochem"},{"key":"957_CR53","first-page":"1","volume":"10","author":"AG Thomas","year":"2015","unstructured":"Thomas AG, Sattler R, Tendyke K, Loiacono KA, Hansen H, Sahni V, et al. High-throughput assay development for cystine-glutamate antiporter (xc-) highlights faster cystine uptake than glutamate release in glioma cells. PLoS One. 2015;10:1\u201320.","journal-title":"PLoS One"},{"key":"957_CR54","doi-asserted-by":"crossref","first-page":"21301","DOI":"10.18632\/oncotarget.4019","volume":"6","author":"J Ching","year":"2015","unstructured":"Ching J, Amiridis S, Stylli SS, Bjorksten AR, Kountouri N, Zheng T, et al. The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells. Oncotarget. 2015;6:21301\u201314.","journal-title":"Oncotarget"},{"key":"957_CR55","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/glia.22656","volume":"62","author":"G Dentesano","year":"2014","unstructured":"Dentesano G, Serratosa J, Tusell JM, Ram\u00f3n P, Valente T, Saura J, et al. CD200R1 and CD200 expression are regulated by PPAR-gamma in activated glial cells. Glia. 2014;62:982\u201398.","journal-title":"Glia"},{"key":"957_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1164\/rccm.201106-1151OC","volume":"190","author":"H Li","year":"2014","unstructured":"Li H, Singh S, Potula R, Persidsky Y, Kanmogne GD. Dysregulation of claudin-5 in HIV-induced interstitial pneumonitis and lung vascular injury: protective role of peroxisome proliferator-activated receptor-gamma. Am J Respir Crit Care Med. 2014;190:85\u201397.","journal-title":"Am J Respir Crit Care Med"},{"key":"957_CR57","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1074\/jbc.M113.536805","volume":"289","author":"SP Lakshmi","year":"2014","unstructured":"Lakshmi SP, Reddy AT, Zhang Y, Sciurba FC, Mallampalli RK, Duncan SR, et al. Down-regulated peroxisome proliferator-activated receptor-gamma (PPARgamma) in lung epithelial cells promotes a PPARgamma agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD). J Biol Chem. 2014;289:6383\u201393.","journal-title":"J Biol Chem"},{"key":"957_CR58","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.4049\/jimmunol.171.12.6827","volume":"171","author":"B Zingarelli","year":"2003","unstructured":"Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, Cook JA. Peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy\u220612,14-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol. 2003;171:6827\u201337.","journal-title":"J Immunol"},{"key":"957_CR59","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"key":"957_CR60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI11918","volume":"107","author":"J Hiscott","year":"2001","unstructured":"Hiscott J, Kwon H, G\u00e9nin P. Hostile takeovers: viral appropriation of the NF-\u03baB pathway. J Clin Invest. 2001;107:143\u201351.","journal-title":"J Clin Invest"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-017-0957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T08:59:00Z","timestamp":1570093140000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-017-0957-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1186\/s12974-017-0957-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]},"article-number":"183"}}